Latest Inhaler Stories
Researchers say as many as 50 percent treatment-resistant asthma cases in kids are misdiagnosed.
HORSHAM, Pa., Sept. 8 /PRNewswire/ -- Teva Pharmaceutical Industries Ltd.
BURLINGTON, Mass., Aug.
For many people afflicted by asthma, treatment can be a frustrating and time-consuming experience.
HORSHAM, Pa., July 28 /PRNewswire/ -- Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR).
SILVER SPRING, Md., July 16 /PRNewswire-USNewswire/ -- The public should be on the lookout for stolen inhalers after some were found in a number of pharmacies.
SILVER SPRING, Md., July 16 /PRNewswire-USNewswire/ -- The FDA is warning the public that certain Advair Diskus inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies.
Armed with the right information, physicians can play a stronger role in ensuring asthma patients don't waver in taking drugs proven to prevent asthma attacks.
WILMINGTON, Del., June 2 /PRNewswire-FirstCall/ -- Today, the U.S. Food and Drug Administration (FDA) released final label revisions for respiratory medications that contain an active ingredient known as a long-acting beta-agonist (LABA).
REDWOOD CITY, Calif., May 18 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).
- A trick or prank.
More Images (2 images) »